Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
